trial summary · NCT06336044
Pre-marketing Trial to Assess Safety and Efficacy of 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'
"Clinical and Instrumental Evaluation of the Safety and Bio-revitalizing Effect on the Face of the Medical Device 'Volumizing Filler Based on Hyaluronic Acid and Recombinant Collagen'"
Trial record from the TrialBase DB dataset, status RECRUITING, condition Wrinkle, sponsored by Taumedika s.r.l.. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
Study to validate the safety and efficacy of the Hyaluronic Acid +Collagen filler 40 patients will undergo through 3 visits one to asses the health and apply the filler one after 4 weeks to check the results one after 16 weeks for the final check and results validation Safety assessed with analysis of the Adverse Events
Source record: https://clinicaltrials.gov/study/NCT06336044
Facts
| registry id | NCT06336044 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | not reported |
| study type | INTERVENTIONAL |
| lead condition | Wrinkle |
| sponsor | Taumedika s.r.l. |
| sponsor class | INDUSTRY |
| enrollment | 40 |
| start date | 2026-11 |
| primary completion | 2027-02 |
| completion | 2027-04 |
| results posted | not reported |
Conditions
- Wrinkle
- Scar
- Laxity; Skin
Interventions
- Karisma
Countries
- Italy
Intervention types: DEVICE
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.